Onconova Therapeutics Inc. (ONTX) NASDAQ

$1 - (-)

Market Cap: $20.90M

As of 04/02/24 12:00 AM EDT. Market closed.

(ONTX)

Onconova Therapeutics Inc. (ONTX)
NASDAQ

$1
- (-)

Market Cap: $20.90M

As of 04/02/24 12:00 AM EDT. Market closed.

Add to Portfolio

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
375 Pheasant Run, Pennsylvania, Newtown, 18940-3423.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Steven Fruchtman
Address
375 Pheasant Run, Pennsylvania, Newtown, 18940-3423.
PRICE CHART FOR ONCONOVA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.97
Previous Close
$1
Days Range
$1 - $1.05
52 week range
$0.55 - $1.45
Volume
1,281,870
Avg. Volume (30 days)
165,066
Market Cap
$20.90M
Dividend Yield
-
P/E
-
Shares Outstanding
21,003,409
Open
$0.97
Previous Close
$1
Days Range
$1 - $1.05
52 week range
$0.55 - $1.45
Volume
1,281,870
Avg. Volume (30 days)
165,066
Market Cap
$20.90M
Dividend Yield
-
P/E
-
Shares Outstanding
21,003,409
FINANCIAL STATEMENTS FOR ONCONOVA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ONCONOVA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Guerin Mark PatrickCFO AND COOMar 14, 2024 Option Exercise$0.902,5912,33235,976Mar 15, 2024, 05:40 PM
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFFMar 14, 2024 Option Exercise$0.908,7277,85474,792Mar 15, 2024, 05:36 PM
Guerin Mark PatrickCFO AND COOFeb 07, 2024 Option Exercise$0.672,4431,63729,901Feb 09, 2024, 05:38 PM
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFFFeb 07, 2024 Option Exercise$0.679,2126,17260,408Feb 09, 2024, 05:36 PM
Guerin Mark PatrickCFO AND COOAug 03, 2023 Option Exercise$1.021,4221,45025,444Aug 04, 2023, 04:45 PM
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFFAug 03, 2023 Option Exercise$1.014,7444,79148,300Aug 04, 2023, 04:42 PM
Guerin Mark PatrickCFO AND COOJun 12, 2023 Option Exercise$1.141,5751,79122,116Jun 13, 2023, 04:54 PM
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFFFeb 07, 2023 Option Exercise$1.366,9779,48940,477Feb 08, 2023, 06:00 PM
Gelder Mark S. MDCHIEF MEDICAL OFFICERFeb 07, 2023 Option Exercise$1.361,2421,68910,487Feb 08, 2023, 05:58 PM
Guerin Mark PatrickCFO AND COOFeb 07, 2023 Option Exercise$1.361,7852,42818,191Feb 08, 2023, 05:56 PM
Guerin Mark PatrickCFO AND COOAug 03, 2022 Option Exercise$1.321,3551,78913,076Aug 04, 2022, 04:38 PM
Gelder Mark S. MDCHIEF MEDICAL OFFICERAug 03, 2022 Option Exercise$1.321,1351,4985,896Aug 04, 2022, 04:34 PM
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFFAug 03, 2022 Option Exercise$1.324,5626,02226,134Aug 04, 2022, 04:30 PM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselJan 28, 2022 Buy$1.671,5002,50524,514Jan 31, 2022, 08:41 AM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselJan 21, 2022 Buy$2.021,5003,03023,014Jan 24, 2022, 08:40 AM
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSELJan 14, 2022 Buy$2.201,5003,30021,514Jan 18, 2022, 09:12 AM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselJan 07, 2022 Buy$2.391,5003,58520,014Jan 10, 2022, 08:39 AM
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSELNov 19, 2021 Buy$3.161,0003,16018,514Nov 23, 2021, 09:20 AM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselNov 18, 2021 Option Exercise$3.005,00015,00017,514Nov 19, 2021, 08:45 AM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselSep 28, 2021 Buy$4.202,38110,00012,515Sep 29, 2021, 08:27 AM
Gelder Mark S. MDChief Medical OfficerSep 28, 2021 Buy$4.202,38110,0002,381Sep 29, 2021, 08:25 AM
Fruchtman Steven MPresident, Chief Executive OffSep 28, 2021 Buy$4.202,38110,00018,130Sep 28, 2021, 12:34 PM
MARINO JAMES JDirectorSep 28, 2021 Buy$4.205,95224,99821,334Sep 28, 2021, 12:32 PM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselFeb 16, 2021 Buy$1.0012,00012,000152,000Feb 17, 2021, 08:57 AM
Guerin Mark PatrickChief Financial OfficerFeb 16, 2021 Buy$1.0015,00015,000145,213Feb 17, 2021, 08:55 AM
Fruchtman Steven MPresident, Chief Executive OffFeb 16, 2021 Buy$1.0020,00020,000236,226Feb 17, 2021, 08:48 AM
MARINO JAMES JDirectorFeb 16, 2021 Buy$1.0025,00025,000230,716Feb 17, 2021, 08:46 AM
Shoemaker Mary TeresaDirectorFeb 16, 2021 Buy$1.0013,00013,00050,735Feb 17, 2021, 08:45 AM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselDec 11, 2020 Buy$0.3230,0009,600140,000Dec 14, 2020, 09:00 AM
Shoemaker Mary TeresaDirectorNov 25, 2020 Buy$0.2637,73510,00037,735Nov 30, 2020, 05:14 PM
Guerin Mark PatrickChief Financial OfficerNov 25, 2020 Buy$0.2616,7554,356125,599Nov 30, 2020, 05:11 PM
Guerin Mark PatrickChief Financial OfficerNov 27, 2020 Buy$0.264,6141,200130,213Nov 30, 2020, 05:11 PM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselNov 25, 2020 Buy$0.2620,0005,120110,000Nov 30, 2020, 05:09 PM
Fruchtman Steven MPresident, Chief Executive OffNov 25, 2020 Buy$0.2640,00010,360216,226Nov 30, 2020, 05:08 PM
MARINO JAMES JDirectorNov 24, 2020 Buy$0.2638,77410,004205,716Nov 27, 2020, 01:34 PM
Reddy E PremkumarDirectorAug 27, 2020 Sale$0.27527,863143,94816,683Aug 31, 2020, 04:49 PM
Hoffman Michael BDirectorAug 27, 2020 Sale$0.27182,49249,62021,919Aug 31, 2020, 04:42 PM
Hoffman Michael BDirectorAug 27, 2020 Sale$0.271,8765100Aug 31, 2020, 04:42 PM
GROOPMAN JEROMEDirectorMay 19, 2020 Buy$0.3610,0003,62610,001May 21, 2020, 05:10 PM
OLER ABRAHAM N.SVP Corp Dev & Gen CounselMay 19, 2020 Buy$0.3715,0005,55090,000May 20, 2020, 09:19 AM
Guerin Mark PatrickChief Financial OfficerMay 19, 2020 Buy$0.3621,0007,560108,844May 20, 2020, 09:09 AM
Fruchtman Steven MPresident, Chief Executive OffMay 19, 2020 Buy$0.3726,8009,857176,226May 20, 2020, 09:07 AM
MEHTA VIRENDirectorNov 25, 2019 Buy$0.20250,00050,000250,857Nov 27, 2019, 08:33 AM
Reddy E PremkumarDirectorNov 25, 2019 Buy$0.20500,000100,000544,546Nov 26, 2019, 07:57 AM
MARINO JAMES JDirectorNov 25, 2019 Buy$0.20150,00030,000166,942Nov 26, 2019, 07:53 AM
Fruchtman Steven MPresident, Chief Executive OffNov 25, 2019 Buy$0.20149,00029,800149,426Nov 26, 2019, 07:51 AM
Guerin Mark PatrickChief Financial OfficerNov 25, 2019 Buy$0.2087,50017,50087,844Nov 26, 2019, 07:50 AM
OLER ABRAHAM N.VP Corp Dev & Gen CounselNov 25, 2019 Buy$0.2075,00015,00075,000Nov 26, 2019, 07:46 AM
MARINO JAMES JDirectorSep 25, 2019 Buy$1.607,26011,61616,942Sep 26, 2019, 06:22 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 24, 2019 Sale$1.1916,70019,873616,389Sep 26, 2019, 04:16 PM
ARMISTICE CAPITAL, LLC10% OwnerSep 23, 2019 Sale$1.2710,24913,016816,702Sep 25, 2019, 05:41 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 23, 2019 Sale$1.2337,24245,968633,089Sep 24, 2019, 04:08 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 20, 2019 Sale$1.6275,119121,430670,331Sep 24, 2019, 04:08 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 18, 2019 Sale$2.1049,995105,015745,450Sep 20, 2019, 04:05 PM
683 Capital Management, LLCFormer 10% OwnerSep 18, 2019 Sale$2.03506,8771,030,684848,151Sep 20, 2019, 03:21 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 11, 2019 Sale$2.751,2473,432795,445Sep 13, 2019, 04:24 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 09, 2019 Sale$2.774001,106796,692Sep 11, 2019, 04:16 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 06, 2019 Sale$2.785,01513,954797,092Sep 09, 2019, 04:10 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerSep 05, 2019 Sale$2.754001,100802,107Sep 09, 2019, 04:10 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerJul 10, 2019 Sale$2.812,7427,697802,507Jul 11, 2019, 04:43 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerJul 09, 2019 Sale$2.848,18523,204805,249Jul 11, 2019, 04:43 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerJun 27, 2019 Sale$3.451,4585,025813,434Jul 01, 2019, 04:35 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerJun 25, 2019 Sale$3.401,3804,689814,892Jun 27, 2019, 04:21 PM
Hoffman Michael BDirectorAug 29, 2018 Sale$0.4529,99913,5215,731,117Aug 29, 2018, 05:22 PM
Hoffman Michael BDirectorAug 28, 2018 Sale$0.4550,00022,5975,791,116Aug 29, 2018, 05:22 PM
Hoffman Michael BDirectorAug 27, 2018 Sale$0.4520,0009,0705,811,116Aug 29, 2018, 05:22 PM
Bienen Henry SDirectorMay 29, 2018 Buy$0.3810,0003,80022,724May 31, 2018, 05:27 PM
683 Capital Management, LLC10% OwnerApr 27, 2018 Buy$0.4311,838,2355,031,25014,503,169May 01, 2018, 05:14 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerApr 27, 2018 Buy$0.4310,147,0584,312,50012,244,080May 01, 2018, 04:12 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerFeb 08, 2018 Buy$1.011,100,0001,111,0002,097,022Feb 12, 2018, 07:12 PM
683 Capital Management, LLC10% OwnerFeb 08, 2018 Buy$1.04200,000207,1202,664,934Feb 12, 2018, 04:37 PM
Bienen Henry SDirectorApr 26, 2017 Buy$2.103,8108,00112,724Apr 28, 2017, 03:12 PM
Guerin Mark PatrickChief Financial OfficerApr 26, 2017 Buy$2.101,4293,0015,155Apr 28, 2017, 03:11 PM
MARINO JAMES JDirectorApr 26, 2017 Buy$2.1011,90625,00336,321Apr 28, 2017, 03:04 PM
Reddy E PremkumarDirectorApr 26, 2017 Buy$2.10119,048250,001385,832Apr 28, 2017, 03:03 PM
Kumar RameshPresident and CEOApr 26, 2017 Buy$2.1023,81050,001102,227Apr 28, 2017, 03:03 PM
TYNDALL CAPITAL PARTNERS L P10% OwnerApr 21, 2017 Option Exercise$2.10476,190999,999997,022Apr 24, 2017, 06:06 PM
Bienen Henry SDirectorJul 29, 2016 Option Exercise$4.107,42030,4228,914Aug 10, 2016, 09:13 PM
Hoffman Michael BDirectorJul 29, 2016 Option Exercise$4.10528,8452,168,264980,673Aug 10, 2016, 08:48 PM
GROOPMAN JEROMEDirectorJun 29, 2016 Option Exercise$5.20105210Aug 10, 2016, 08:39 PM
MARINO JAMES JDirectorAug 01, 2016 Option Exercise$4.1024,405100,06024,415Aug 10, 2016, 08:32 PM
Kumar RameshPresident and CEOJul 29, 2016 Option Exercise$4.1050,765208,13678,417Aug 10, 2016, 08:30 PM
Guerin Mark PatrickChief Accounting OfficerJul 29, 2016 Option Exercise$4.103,66615,0313,726Aug 10, 2016, 08:24 PM
Fruchtman Steven MChief Medical OfficerJul 29, 2016 Option Exercise$4.106,27625,7326,376Aug 10, 2016, 08:23 PM
Reddy E PremkumarDirectorJul 29, 2016 Option Exercise$4.10133,000545,300266,784Aug 10, 2016, 08:21 PM
Fruchtman Steven MChief Medical OfficerJun 24, 2016 Option Exercise$6.50100650100Jun 30, 2016, 05:26 PM
Maniar ManojSVP - Product DevelopmentJun 30, 2016 Option Exercise$6.505032550Jun 30, 2016, 05:24 PM
MARINO JAMES JDirectorJun 27, 2016 Option Exercise$5.20105210Jun 29, 2016, 09:08 PM
Reddy E PremkumarDirectorMay 02, 2014 Option Exercise$1.3327,08436,0221,337,838Feb 03, 2015, 05:47 PM
Hoffman Michael BDirectorJul 07, 2014 Option Exercise$2.6718,75450,07318,754Jul 09, 2014, 05:20 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerFeb 21, 2014 Buy$8.9171,740639,2034,518,275Feb 24, 2014, 07:51 AM
Michael & Jane Hoffman 2013 Descendants10% OwnerFeb 20, 2014 Buy$8.0371,740576,0724,446,535Feb 24, 2014, 07:51 AM
Hoffman Michael BDirectorFeb 21, 2014 Buy$8.9171,740639,2034,518,275Feb 24, 2014, 07:50 AM
Hoffman Michael BDirectorFeb 20, 2014 Buy$8.0371,740576,0724,446,535Feb 24, 2014, 07:50 AM
Kumar RameshPresident and CEOFeb 07, 2014 Option Exercise$6.0013,54381,258290,043Feb 11, 2014, 08:33 PM
Kumar RameshPresident and CEOFeb 10, 2014 Option Exercise$6.0020,000120,000296,500Feb 11, 2014, 08:33 PM
Kumar RameshPresident and CEOFeb 07, 2013 Sale$15.0213,543203,416276,500Feb 11, 2014, 08:33 PM
Kumar RameshPresident and CEOFeb 10, 2014 Sale$15.1120,000302,200276,500Feb 11, 2014, 08:33 PM
Kumar RameshPresident and CEOFeb 03, 2014 Option Exercise$6.0020,000120,000296,500Feb 03, 2014, 08:25 PM
Kumar RameshPresident and CEOJan 31, 2014 Option Exercise$6.0020,000120,000296,500Feb 03, 2014, 08:25 PM
Kumar RameshPresident and CEOJan 30, 2014 Option Exercise$5.1220,000102,498296,500Feb 03, 2014, 08:25 PM
Kumar RameshPresident and CEOFeb 03, 2014 Sale$15.0720,000301,400276,500Feb 03, 2014, 08:25 PM
Kumar RameshPresident and CEOJan 31, 2014 Sale$15.0320,000300,600276,500Feb 03, 2014, 08:25 PM
Kumar RameshPresident and CEOJan 30, 2014 Sale$15.0520,000301,000276,500Feb 03, 2014, 08:25 PM
Hoffman Michael BDirectorJan 27, 2014 Buy$11.8625,589303,4864,374,795Jan 27, 2014, 09:41 PM
Hoffman Michael BDirectorJan 24, 2014 Buy$11.9631,706379,2044,349,206Jan 27, 2014, 09:41 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerJan 27, 2014 Buy$11.8625,589303,4864,374,795Jan 27, 2014, 09:39 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerJan 24, 2014 Buy$11.9631,706379,2044,349,206Jan 27, 2014, 09:39 PM
Reddy E PremkumarDirectorDec 19, 2013 Option Exercise$1.3332,03642,6081,310,754Dec 24, 2013, 02:19 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerNov 22, 2013 Buy$14.395,00071,9484,317,500Nov 25, 2013, 03:37 PM
Hoffman Michael BDirectorNov 22, 2013 Buy$14.395,00071,9484,317,500Nov 25, 2013, 03:35 PM
Hoffman Michael BDirectorNov 18, 2013 Buy$11.875,00059,3504,312,500Nov 20, 2013, 03:12 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerNov 18, 2013 Buy$11.875,00059,3504,312,500Nov 20, 2013, 03:11 PM
Reddy E PremkumarDirectorNov 18, 2013 Buy$12.105,00060,5001,278,718Nov 19, 2013, 02:14 PM
Hoffman Michael BDirectorNov 15, 2013 Buy$11.9919,700236,2654,307,500Nov 18, 2013, 08:35 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerNov 15, 2013 Buy$11.9919,700236,2654,307,500Nov 18, 2013, 08:32 PM
Kumar RameshPresident and CEONov 15, 2013 Buy$12.021,10013,222276,500Nov 18, 2013, 08:29 PM
Bienen Henry SDirectorNov 15, 2013 Buy$12.171,40017,03814,935Nov 18, 2013, 08:27 PM
Altland JamesSVP, Finance & Corp. Develop.Oct 10, 2013 Option Exercise$6.005,00030,00010,000Oct 15, 2013, 10:36 AM
Reddy E PremkumarDirectorJul 25, 2013 Buy$22.721,00022,7241,273,718Aug 02, 2013, 10:57 AM
MEHTA VIRENDirectorJul 30, 2013 Buy$15.0016,667250,005126,914Aug 01, 2013, 04:13 PM
Kumar RameshPresident and CEOJul 30, 2013 Buy$15.006,667100,005275,400Aug 01, 2013, 04:13 PM
Michael & Jane Hoffman 2013 Descendants10% OwnerJul 30, 2013 Buy$15.001,000,00015,000,0004,287,800Aug 01, 2013, 04:12 PM
Hoffman Michael BDirectorJul 30, 2013 Buy$15.001,000,00015,000,0004,372,330Aug 01, 2013, 04:11 PM
Reddy E PremkumarDirectorJul 30, 2013 Buy$15.0020,000300,0001,272,718Aug 01, 2013, 04:09 PM
Bienen Henry SDirectorJul 30, 2013 Buy$15.006,667100,00513,535Aug 01, 2013, 04:08 PM
Altland JamesSVP, Finance & Corp. Develop.Jul 30, 2013 Option Exercise$6.005,00030,0005,000Aug 01, 2013, 04:08 PM
MCKEARN THOMAS JPresident, R&DJul 30, 2013 Buy$15.003,33349,9953,333Aug 01, 2013, 04:07 PM
Baxter Healthcare SA10% OwnerJul 30, 2013 Buy$15.00330,0004,950,0002,603,295Aug 01, 2013, 04:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Guerin Mark PatrickCFO AND COO03/14/20242,332
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFF03/14/20247,854
Guerin Mark PatrickCFO AND COO02/07/20241,637
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFF02/07/20246,172
Guerin Mark PatrickCFO AND COO08/03/20231,450
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFF08/03/20234,791
Guerin Mark PatrickCFO AND COO06/12/20231,791
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFF02/07/20239,489
Gelder Mark S. MDCHIEF MEDICAL OFFICER02/07/20231,689
Guerin Mark PatrickCFO AND COO02/07/20232,428
Guerin Mark PatrickCFO AND COO08/03/20221,789
Gelder Mark S. MDCHIEF MEDICAL OFFICER08/03/20221,498
Fruchtman Steven MPRESIDENT, CHIEF EXECUTIVE OFF08/03/20226,022
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel01/28/20222,505
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel01/21/20223,030
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSEL01/14/20223,300
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel01/07/20223,585
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSEL11/19/20213,160
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel11/18/202115,000
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel09/28/202110,000
Gelder Mark S. MDChief Medical Officer09/28/202110,000
Fruchtman Steven MPresident, Chief Executive Off09/28/202110,000
MARINO JAMES JDirector09/28/202124,998
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel02/16/202112,000
Guerin Mark PatrickChief Financial Officer02/16/202115,000
Fruchtman Steven MPresident, Chief Executive Off02/16/202120,000
MARINO JAMES JDirector02/16/202125,000
Shoemaker Mary TeresaDirector02/16/202113,000
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel12/11/20209,600
Shoemaker Mary TeresaDirector11/25/202010,000
Guerin Mark PatrickChief Financial Officer11/25/20204,356
Guerin Mark PatrickChief Financial Officer11/27/20201,200
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel11/25/20205,120
Fruchtman Steven MPresident, Chief Executive Off11/25/202010,360
MARINO JAMES JDirector11/24/202010,004
Reddy E PremkumarDirector08/27/2020143,948
Hoffman Michael BDirector08/27/202049,620
Hoffman Michael BDirector08/27/2020510
GROOPMAN JEROMEDirector05/19/20203,626
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel05/19/20205,550
Guerin Mark PatrickChief Financial Officer05/19/20207,560
Fruchtman Steven MPresident, Chief Executive Off05/19/20209,857
MEHTA VIRENDirector11/25/201950,000
Reddy E PremkumarDirector11/25/2019100,000
MARINO JAMES JDirector11/25/201930,000
Fruchtman Steven MPresident, Chief Executive Off11/25/201929,800
Guerin Mark PatrickChief Financial Officer11/25/201917,500
OLER ABRAHAM N.VP Corp Dev & Gen Counsel11/25/201915,000
MARINO JAMES JDirector09/25/201911,616
TYNDALL CAPITAL PARTNERS L P10% Owner09/24/201919,873
ARMISTICE CAPITAL, LLC10% Owner09/23/201913,016
TYNDALL CAPITAL PARTNERS L P10% Owner09/23/201945,968
TYNDALL CAPITAL PARTNERS L P10% Owner09/20/2019121,430
TYNDALL CAPITAL PARTNERS L P10% Owner09/18/2019105,015
683 Capital Management, LLCFormer 10% Owner09/18/20191,030,684
TYNDALL CAPITAL PARTNERS L P10% Owner09/11/20193,432
TYNDALL CAPITAL PARTNERS L P10% Owner09/09/20191,106
TYNDALL CAPITAL PARTNERS L P10% Owner09/06/201913,954
TYNDALL CAPITAL PARTNERS L P10% Owner09/05/20191,100
TYNDALL CAPITAL PARTNERS L P10% Owner07/10/20197,697
TYNDALL CAPITAL PARTNERS L P10% Owner07/09/201923,204
TYNDALL CAPITAL PARTNERS L P10% Owner06/27/20195,025
TYNDALL CAPITAL PARTNERS L P10% Owner06/25/20194,689
Hoffman Michael BDirector08/29/201813,521
Hoffman Michael BDirector08/28/201822,597
Hoffman Michael BDirector08/27/20189,070
Bienen Henry SDirector05/29/20183,800
683 Capital Management, LLC10% Owner04/27/20185,031,250
TYNDALL CAPITAL PARTNERS L P10% Owner04/27/20184,312,500
TYNDALL CAPITAL PARTNERS L P10% Owner02/08/20181,111,000
683 Capital Management, LLC10% Owner02/08/2018207,120
Bienen Henry SDirector04/26/20178,001
Guerin Mark PatrickChief Financial Officer04/26/20173,001
MARINO JAMES JDirector04/26/201725,003
Reddy E PremkumarDirector04/26/2017250,001
Kumar RameshPresident and CEO04/26/201750,001
TYNDALL CAPITAL PARTNERS L P10% Owner04/21/2017999,999
Bienen Henry SDirector07/29/201630,422
Hoffman Michael BDirector07/29/20162,168,264
GROOPMAN JEROMEDirector06/29/201652
MARINO JAMES JDirector08/01/2016100,060
Kumar RameshPresident and CEO07/29/2016208,136
Guerin Mark PatrickChief Accounting Officer07/29/201615,031
Fruchtman Steven MChief Medical Officer07/29/201625,732
Reddy E PremkumarDirector07/29/2016545,300
Fruchtman Steven MChief Medical Officer06/24/2016650
Maniar ManojSVP - Product Development06/30/2016325
MARINO JAMES JDirector06/27/201652
Reddy E PremkumarDirector05/02/201436,022
Hoffman Michael BDirector07/07/201450,073
Michael & Jane Hoffman 2013 Descendants10% Owner02/21/2014639,203
Michael & Jane Hoffman 2013 Descendants10% Owner02/20/2014576,072
Hoffman Michael BDirector02/21/2014639,203
Hoffman Michael BDirector02/20/2014576,072
Kumar RameshPresident and CEO02/07/201481,258
Kumar RameshPresident and CEO02/10/2014120,000
Kumar RameshPresident and CEO02/07/2013203,416
Kumar RameshPresident and CEO02/10/2014302,200
Kumar RameshPresident and CEO02/03/2014120,000
Kumar RameshPresident and CEO01/31/2014120,000
Kumar RameshPresident and CEO01/30/2014102,498
Kumar RameshPresident and CEO02/03/2014301,400
Kumar RameshPresident and CEO01/31/2014300,600
Kumar RameshPresident and CEO01/30/2014301,000
Hoffman Michael BDirector01/27/2014303,486
Hoffman Michael BDirector01/24/2014379,204
Michael & Jane Hoffman 2013 Descendants10% Owner01/27/2014303,486
Michael & Jane Hoffman 2013 Descendants10% Owner01/24/2014379,204
Reddy E PremkumarDirector12/19/201342,608
Michael & Jane Hoffman 2013 Descendants10% Owner11/22/201371,948
Hoffman Michael BDirector11/22/201371,948
Hoffman Michael BDirector11/18/201359,350
Michael & Jane Hoffman 2013 Descendants10% Owner11/18/201359,350
Reddy E PremkumarDirector11/18/201360,500
Hoffman Michael BDirector11/15/2013236,265
Michael & Jane Hoffman 2013 Descendants10% Owner11/15/2013236,265
Kumar RameshPresident and CEO11/15/201313,222
Bienen Henry SDirector11/15/201317,038
Altland JamesSVP, Finance & Corp. Develop.10/10/201330,000
Reddy E PremkumarDirector07/25/201322,724
MEHTA VIRENDirector07/30/2013250,005
Kumar RameshPresident and CEO07/30/2013100,005
Michael & Jane Hoffman 2013 Descendants10% Owner07/30/201315,000,000
Hoffman Michael BDirector07/30/201315,000,000
Reddy E PremkumarDirector07/30/2013300,000
Bienen Henry SDirector07/30/2013100,005
Altland JamesSVP, Finance & Corp. Develop.07/30/201330,000
MCKEARN THOMAS JPresident, R&D07/30/201349,995
Baxter Healthcare SA10% Owner07/30/20134,950,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ONCONOVA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.248,8810%No changeOther
RENAISSANCE TECHNOLOGIES LLC198,8410.00023%8.25%Other
GEODE CAPITAL MANAGEMENT, LLC192,8580.00002%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ONCONOVA THERAPEUTICS INC
STOCK BUYBACKS FOR ONCONOVA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.11%
1Q
09/30/2023
03/31/2023
0.20%
2Q
09/30/2023
12/31/2022
0.37%
3Q
09/30/2023
09/30/2022
0.42%
4Q
09/30/2023
06/30/2022
0.47%
5Q
09/30/2023
03/31/2022
0.47%
6Q
09/30/2023
12/31/2021
24.78%
7Q
09/30/2023
09/30/2021
31.44%
8Q
09/30/2023
06/30/2021
33.09%
9Q
09/30/2023
03/31/2021
43.70%
10Q
09/30/2023
12/31/2020
70.06%
11Q
09/30/2023
09/30/2020
74.18%
12Q
09/30/2023
06/30/2020
85.81%
13Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.11%
1Q
03/31/2023
0.20%
2Q
12/31/2022
0.37%
3Q
09/30/2022
0.42%
4Q
06/30/2022
0.47%
5Q
03/31/2022
0.47%
6Q
12/31/2021
24.78%
7Q
09/30/2021
31.44%
8Q
06/30/2021
33.09%
9Q
03/31/2021
43.70%
10Q
12/31/2020
70.06%
11Q
09/30/2020
74.18%
12Q
06/30/2020
85.81%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ONCONOVA THERAPEUTICS INC
LOADING...